Stocks · Korea
009300
KOSDAQ
Sam-A Pharm
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
PER6.60x
PBR0.37x
EPS2,120 KRW
BPS37,375 KRW
ROE3.93%
Dividend yield6.08%
DPS850 KRW
Payout ratio40.09%
Returns and 52-week range
1W+0.21%
1M+0.29%
3M+8.45%
6M-11.96%
1Y-18.90%
YTD-9.39%
52W high17,320원
52W low11,950원
From 52W high-19.23%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 817억 | 183억 | 119억 | 22.3% |
| 2023 | 972억 | 235억 | 214억 | 24.2% |
| 2024 | 956억 | 245억 | 221억 | 25.6% |
| 2025 | 778억 | 110억 | 129억 | 14.1% |
| Quarterly | ||||
| 2024 4Q | 196억 | 39억 | 43억 | 19.8% |
| 2025 1Q | 245억 | 74억 | 63억 | 30.4% |
| 2025 2Q | 174억 | 20억 | 27억 | 11.5% |
| 2025 3Q | 151억 | -11억 | -54,064,749원 | -7.4% |
| 2025 4Q | 208억 | 27억 | 40억 | 12.8% |
| 2026 1Q | 176억 | 21억 | 22억 | 11.8% |
Company
Address: 강원도 원주시 문막읍 동화공단로 49
Peers in the same sector
Recent filings
- 2026-08-13반기보고서 (2026.06)
- 2026-05-14분기보고서 (2026.03)
- 2026-04-22[기재정정]사업보고서 (2025.12)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.